Choong Ang Vaccine Laboratory Co. Ltd

072020 · KQ · Healthcare / Drug Manufacturers - Specialty & Generic

9,070.00KRW+40.00 (+0.44%)

Price History

Full chart

Market Stats

Previous Close9,030.00

Open9,100.00

Day Range8,990.00 – 9,100.00

52-Week Range8,560.00 – 10,350.00

Volume14.87K

Market Cap84.24B

P/E (TTM)0.00

Forward P/E22.52

Dividend Yield2.19%

Beta0.47

50-Day Avg9,220.60

200-Day Avg9,446.75

About

Choong Ang Vaccine Laboratory Co., Ltd. engages in the research, development, manufacturing, and sale of animal vaccines in South Korea, Asia, Africa, and the United States. It offers swine, poultry, cattle, canine, feline, wild boar, and raccoon vaccines under the SuiShot, PoulShot, BoviShot, CaniShot, and FeliShot brands. The company was founded in 1968 and is headquartered in Daejeon, South Korea.

Company Details

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. In-Joong Yoon
Employees167
Headquarters1476-37 Yuseong-daero, Daejeon, South Korea, 34055, Korea
Websitehttps://cavac.co.kr

Leadership

Mr. In-Joong YoonChief Executive Officer & Chairman · b. 1962

Financials

Income Statement

Currency: KRW	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	-	-	-	-	29.61B	34.60B	37.90B	31.87B	33.15B	32.90B	36.32B	40.91B	39.30B	41.87B	45.59B	49.07B
Growth (%)	-	-	-	-	-	+16.87%	+9.52%	-15.92%	+4.04%	-0.75%	+10.38%	+12.66%	-3.95%	+6.54%	+8.90%	+7.62%
Cost of Revenue	-	-	-	-	16.97B	22.39B	21.02B	16.73B	19.48B	18.95B	19.47B	21.88B	20.50B	20.33B	24.28B	25.18B
Gross Profit	-	-	-	-	12.63B	12.21B	16.88B	15.14B	13.67B	13.95B	16.85B	19.03B	18.79B	21.53B	21.31B	23.89B
Gross Margin	-	-	-	-	42.67%	35.29%	44.53%	47.51%	41.23%	42.40%	46.39%	46.52%	47.82%	51.43%	46.74%	48.68%
Operating Expense	-	-	-	-	7.10B	8.58B	9.94B	9.59B	10.16B	11.24B	12.82B	14.49B	14.51B	14.56B	15.55B	17.41B
Operating Income	-	-	-	-	5.54B	3.63B	6.94B	5.55B	3.50B	2.71B	4.03B	4.54B	4.28B	6.97B	5.76B	6.48B
Operating Margin	-	-	-	-	18.70%	10.50%	18.31%	17.41%	10.57%	8.25%	11.10%	11.10%	10.90%	16.66%	12.63%	13.20%
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	11.10B	13.34B	13.69B	13.09B
EBITDA Margin	-	-	-	-	-	-	-	-	-	-	-	-	28.25%	31.86%	30.02%	26.68%
Net Income	-	-	-	-	4.28B	3.25B	6.21B	4.58B	3.45B	1.85B	3.16B	7.60B	4.04B	6.00B	6.85B	6.16B
Net Income Margin	-	-	-	-	14.47%	9.40%	16.38%	14.37%	10.42%	5.64%	8.71%	18.58%	10.29%	14.33%	15.02%	12.55%
R&D	-	-	-	-	916.27M	1.59B	1.76B	1.47B	1.63B	1.76B	1.75B	1.81B	1.66B	1.56B	1.89B	2.25B
R&D as % of Total Revenue	-	-	-	-	3.09%	4.60%	4.64%	4.61%	4.92%	5.34%	4.83%	4.42%	4.22%	3.74%	4.14%	4.58%
Interest Expense	0	0	0	0	0	0	0	0	0	0	94.05M	109.67M	242.17M	345.46M	239.26M	214.68M
Interest Expense % of Total Revenue	-	-	-	-	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.26%	0.27%	0.62%	0.83%	0.52%	0.44%

Balance Sheet

Currency: KRW	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	-	-	-	-	60.60B	62.10B	73.54B	81.62B	96.74B	96.57B	104.98B	112.95B	114.86B	119.59B	123.28B	122.82B
Total Liabilities	-	-	-	-	8.61B	7.22B	13.18B	16.95B	11.74B	10.20B	17.43B	19.98B	19.55B	19.79B	19.41B	17.45B
Total Equity	-	-	-	-	51.99B	54.88B	60.37B	64.68B	85.00B	86.37B	87.55B	92.98B	95.30B	99.80B	103.87B	105.37B
Cash	-	-	-	-	7.41B	8.79B	14.47B	9.95B	10.98B	13.40B	12.28B	2.80M	4.05M	2.84M	2.00M	10.47B
Total Debt	-	-	-	-	-	-	6.59B	8.50B	5.40B	4.16B	10.14B	-	-	-	-	-
Net Debt	-	-	-	-	-	-	-	-	-	-	-	305.50M	4.37B	-	-	-

Cash Flow

Currency: KRW	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	5.26B	4.94B	4.94B	5.16B	6.67B	9.93B	7.71B	7.56B	5.71B	8.30B	8.32B	11.53B	7.09B	12.71B	13.40B	7.87B
Investing Cash Flow	-6.25B	-4.46B	-4.46B	-7.84B	-1.47B	-4.89B	-7.97B	-13.47B	-18.47B	-3.97B	-13.15B	-12.00B	-9.18B	-3.42B	-10.02B	-
Financing Cash Flow	133.05M	-187.32M	-187.32M	3.03B	-14.65M	-3.47B	5.82B	1.54B	13.93B	-2.01B	3.93B	-876.90M	-1.60B	-2.81B	-4.78B	-
Capital Expenditure	4.11B	1.76B	1.76B	12.43B	3.35B	3.04B	7.22B	13.18B	5.89B	6.71B	15.40B	14.31B	7.10B	1.92B	7.17B	5.98B
Free Cash Flow	-	-	-	-	-	-	-	-	-	-	-7.09B	-2.84B	-83.84M	10.79B	6.23B	1.90B
Dividends Paid	366.00M	366.00M	366.00M	366.00M	366.00M	366.00M	366.00M	366.00M	366.00M	497.93M	497.93M	690.11M	975.87M	966.63M	1.45B	1.62B
FCF to OCF	-	-	-	-	-	-	-	-	-	-	-85.24%	-24.64%	-1.18%	84.91%	46.50%	24.08%
Dividend Paid to FCF	-	-	-	-	-	-	-	-	-	-	-7.02%	-24.30%	-1163.90%	8.96%	23.25%	85.74%

Earnings

Report Date	Mar 31, 2009	Jun 30, 2009	Sep 30, 2009	Dec 31, 2009	Mar 31, 2010	Jun 30, 2010	Sep 30, 2010	Dec 31, 2010	Mar 31, 2011	Jun 30, 2011	Sep 30, 2011	Dec 31, 2011	Mar 31, 2012	Jun 30, 2012	Sep 30, 2012	Dec 31, 2012	Mar 31, 2013	Jun 30, 2013	Sep 30, 2013	Dec 31, 2013	Mar 31, 2014	Jun 30, 2014	Dec 3, 2014	Feb 25, 2015	Jun 3, 2015	Sep 2, 2015	Dec 2, 2015	Mar 2, 2016	May 13, 2016	Aug 10, 2016	Nov 2, 2016	Feb 3, 2017	May 8, 2017	Aug 7, 2017	Nov 1, 2017	Jan 31, 2018	May 7, 2018	Aug 8, 2018	Nov 6, 2018	Jan 29, 2019	May 14, 2019	Aug 28, 2019	Nov 14, 2019	Feb 26, 2020	May 12, 2020	Sep 2, 2020	Nov 12, 2020	Mar 17, 2021	May 14, 2021	Aug 13, 2021	Nov 16, 2021	Feb 17, 2022	May 16, 2022	Aug 26, 2022	Nov 28, 2022	Feb 13, 2023	May 15, 2023	Aug 14, 2023	Nov 14, 2023	Feb 8, 2024	May 14, 2024	Aug 14, 2024	Nov 12, 2024	Mar 24, 2025	May 2, 2025	Aug 12, 2025	Nov 12, 2025	Dec 31, 2025	Apr 30, 2026	Jun 30, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	184.93	131.75	116.90	153.17	150.77	140.21	119.40	92.88	71.05	106.26	92.07	-7.74	183.55	90.15	124.17	85.26	113.34	135.20	102.74	140.46	169.37	123.32	140.75	40.06	1.75	45.94	112.61	199.34	126.70	149.87	183.48	226.14	82.35	130.69	194.93	98.11	240.35	76.00	28.00	68.00	99.31	-61.65	121.02	27.50	170.17	212.13	87.08	-149.90	166.48	216.19	150.66	237.75	230.49	154.53	203.18	-174.55	191.88	68.66	142.26	218.19	172.83	216.10	97.59	227.70	222.44	72.30	181.34	179.00	352.40	139.24
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	Pre-market	Pre-market	After-hours	Pre-market	Pre-market	Pre-market	After-hours	Pre-market	After-hours	-	Pre-market	Pre-market	-	-	-	-	-	-	-	-	-	-	-	Pre-market	Pre-market	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	-	Pre-market	Pre-market	Pre-market	-	Pre-market	-

Key Statistics & Ratios

Market Cap84.24B

Enterprise Value63.95B

Trailing P/E0.00

Forward P/E22.52

Price / Sales2.15

Price / Book0.78

Revenue (TTM)39.19B

Gross Profit (TTM)18.66B

EBITDA10.01B

Profit Margin9.31%

Operating Margin18.54%

Return on Equity3.83%

Return on Assets2.18%

Shares Outstanding9.26M

Shares Float6.14M

Beta0.47

Dividend Yield2.19%

Dividend Rate200.00

Payout Ratio23.47%

Dividends

20251×

200.00Dec 29, 2025

20241×

170.00Dec 27, 2024

20231×

150.00Dec 27, 2023

20221×

100.00Dec 28, 2022

20211×

100.00Dec 29, 2021

20201×

70.00Dec 29, 2020

20191×

50.00Dec 27, 2019

20181×

50.00Dec 27, 2018

20171×

40.45Dec 27, 2017

20161×

40.45Dec 28, 2016

20151×

40.45Dec 29, 2015

20141×

40.45Dec 29, 2014

20131×

40.45Dec 27, 2013

20121×

40.45Dec 27, 2012

20111×

40.45Dec 28, 2011

20101×

40.45Dec 29, 2010

20091×

40.45Dec 29, 2009

20081×

40.45Dec 29, 2008

20071×

40.45Dec 27, 2007

20061×

39.16Dec 27, 2006

20051×

31.33Dec 28, 2005

20041×

31.33Dec 29, 2004

Stock Splits

Jul 18, 20186:5
Jun 1, 2018205:199
Jun 26, 20071098:1063